Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance
Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, et al.
iScience (2020) Vol. 24, Iss. 1, pp. 101992-101992
Open Access | Times Cited: 79

Showing 51-75 of 79 citing articles:

High-throughput design of symmetrical dimeric SARS-CoV-2 main protease: structural and physical insights into hotspots for adaptation and therapeutics
Aditya K. Padhi, Timir Tripathi
Physical Chemistry Chemical Physics (2022) Vol. 24, Iss. 16, pp. 9141-9145
Closed Access | Times Cited: 7
Screening of potential bio-molecules fromMoringa oliferaagainst SARS-CoV-2 main protease using computational approaches
Shalini Mathpal, Priyanka Sharma, Tushar Joshi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 9885-9896
Closed Access | Times Cited: 10
Effect of Genomic and Amino Acid Sequence Mutation on Virulence and Therapeutic Target of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2)
Endriyas Kelta Wabalo, Abebe Dukessa Dubiwak, Mengistu Welde, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 2187-2192
Open Access | Times Cited: 9
A computational study on active constituents ofHabb-ul-aasandTabasheeras inhibitors of SARS-CoV-2 main protease
Shariq Shamsi, Hina Anjum, Mohd Shahbaaz, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 7702-7713
Closed Access | Times Cited: 7
Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions
Anant Narayan Bhatt, Abhishek Kumar, Yogesh Rai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 7
A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report
Stephen A. Chitty, Sarah Mobbs, Brian S. Rifkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Investigation of SARS-CoV-2 lineages and mutations circulating in a university-affiliated hospital in South Korea analyzed using Oxford Nanopore MinION sequencing
Hyaekang Kim, Sung Hee Chung, Hyun Soo Kim, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 5, pp. 360-369
Open Access | Times Cited: 4
Uncovering the secrets of resistance: An introduction to computational methods in infectious disease research
Aditya K. Padhi, Shweata Maurya
Advances in protein chemistry and structural biology (2024), pp. 173-220
Closed Access
Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design
Amar Jeet Yadav, S Rajesh Kumar, Shweata Maurya, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 18, pp. 14046-14061
Closed Access
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication
S. Das, Sreyashi Nath, Shahjahan, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 801-823
Closed Access
Computational Investigation of Novel Synthetic Analogs of C-1’β Substituted Remdesivir against RNA-dependent RNA-polymerase of SARS-CoV-2
Savio Cardoza, Anirudh Singh, Souvik Sur, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36786-e36786
Open Access
Recent Advances of Nipah Virus Disease: Pathobiology to Treatment and Vaccine Advancement
Sagnik Saha, Manojit Bhattacharya, Sang‐Soo Lee, et al.
The Journal of Microbiology (2024)
Closed Access
High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination
Yesseinia Angleró-Rodríguez, Florian A. Lempp, Megha Subramanian, et al.
Nucleic Acids Research (2024)
Open Access
Therapeutic p28 peptide targets essential H1N1 influenza virus proteins: insights from docking and molecular dynamics simulations
Santanu Sasidharan, Vijayakumar Gosu, Donghyun Shin, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1929-1943
Open Access | Times Cited: 4
Reappraisal of Trifluperidol Against Nsp3 As a Potential Therapeutic for Novel COVID-19: A Molecular Docking and Dynamics Study
Ajita Pandey, Mohit Sharma
Future Virology (2021) Vol. 16, Iss. 7, pp. 491-506
Open Access | Times Cited: 4
Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized?
Jessica M. Conway, Pia Abel zur Wiesch
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1181-1181
Open Access | Times Cited: 4
POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2
Muhammad Torequl Islam
FARMACIA (2021) Vol. 69, Iss. 6, pp. 1001-1017
Open Access | Times Cited: 4
Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2
Ahmed H. Bakheit, Quaiser Saquib, Sarfaraz Ahmed, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2175-2175
Open Access | Times Cited: 1
Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches
Hemlata Pundir, Tanuja Joshi, Manish Pant, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 24, pp. 13366-13377
Closed Access | Times Cited: 3
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
Aditya K. Padhi, Timir Tripathi
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 2
Challenges in designing antiviral agents
Igor José dos Santos Nascimento, Leandro Rocha Silva, Edeildo Ferreira da Silva‐Júnior
Elsevier eBooks (2022), pp. 169-209
Closed Access | Times Cited: 2
Structural Proteomics-Driven Targeted Design of Favipiravir-Binding Site in The RdRp of SARS-CoV-2 Unravels Susceptible Hotspots and Resistance Mutations
Aditya K. Padhi, Jagneshwar Dandapat, Vladimir N. Uversky, et al.
(2021)
Open Access | Times Cited: 2
RNA-DEPENDENT RNA POLYMERASE (RDRP) INHIBITOR DRUGS AGAINST SARS-COV-2: A MOLECULAR DOCKING STUDY
Sarah Gado, Zeynep Ates Alagöz
Ankara Universitesi Eczacilik Fakultesi Dergisi (2022), pp. 62-77
Open Access | Times Cited: 1
Glycolytic Inhibitor 2-Deoxy-D-Glucose Attenuates SARS-CoV-2 Multiplication in Host Cells and Weakens the Infective Potential of Progeny Virions
Anant Narayan Bhatt, Abhishek Kumar, Yogesh Rai, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 1
Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC
Shipra Singhal, Aman Sharma, Anirudh Malik, et al.
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 7, pp. 577-585
Closed Access

Scroll to top